Brief Research Report
Published on 19 Feb 2026
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience
in Cancer Immunity and Immunotherapy
- 296 views